A group of proteins known as toll-like receptors (TLRs) are essential components of the innate immune system. They are single, membrane-spanning, non-catalytic receptors that recognize structurally conserved molecules derived from microbes and are typically expressed in sentinel cells like macrophages and dendritic cells. Once these microbes have gotten past physical barriers like the skin or mucosa of the gastrointestinal tract, TLRs recognize them and trigger immune cell responses.
TLR1 through TLR13 are among the TLRs, along with TLR2, TLR3, TLR4, TLR5, TLR6, TLR7, TLR8, TLR9, TLR10, TLR11, TLR12, and TLR13. Toll-Like Receptors (TLRs) are involved in both the detection of endogenous danger signals and the early innate immune response to encroaching pathogens. TLRs are homologs of the Drosophila Toll protein, which was found to be crucial for defense against microbial infection. They are evolutionarily conserved receptors. TLRs identify pathogen-associated microbial patterns (PAMPs), which are only expressed by microbial pathogens and are highly conserved structural motifs.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V78441 | Biotin-labeled ODN 1668 sodium | Biotin-labeled ODN 1668 (sodium) is a class B CpG ODN and a TLR9 agonist. | |
![]() |
V78442 | Biotin-labeled ODN 1826 sodium | Biotin-labeled ODN 1826 (sodium) is a class B CpG ODN and a TLR9 agonist. | |
![]() |
V78443 | Biotin-labeled ODN 2088 sodium | Biotin-labeled ODN 2088 (sodium) is a TLR3, TLR7 and TLR9 inhibitor. | |
![]() |
V78444 | Biotin-labeled ODN 2216 sodium | Biotin-labeled ODN 2216 (sodium) is a TLR9 agonist. | |
![]() |
V78445 | Biotin-labeled ODN 2395 sodium | Biotin-labeled ODN 2395 (sodium) is a class C CpG ODN and a TLR9 agonist. | |
![]() |
V78446 | Biotin-labeled ODN TTAGGG sodium | Biotin-labeled ODN TTAGGG (sodium) is an inhibitor oligonucleotide that is an antagonist of TLR9, AIM2 and cGAS. | |
![]() |
V87025 | BNT411 | 2296821-50-4 | BNT411 is a selective TLR7 agonist that can induce IFNa release in vitro and in vivo. |
![]() |
V74356 | Cavrotolimod (AST-008) | 2378664-12-9 | Cavrotolimod is a spherical nucleic acid (SNA) modified with B-type CpG oligonucleotides that stimulates TLR9 and elicits an immune response. |
![]() |
V78661 | Cavrotolimod sodium (AST-008 sodium) | Cavrotolimodsodium is a spherical nucleic acid (SNA) modified with B-type CpG oligonucleotides that stimulates TLR9 and elicits an immune response. | |
![]() |
V74376 | CAY10614 | 1202208-36-3 | CAY10614 is a potent TLR4 antagonist. |
![]() |
V74360 | Chitohexaose hexahydrochloride | 127171-88-4 | Chitohexaose hexa HCl is a chitosan oligosaccharide with anti-inflammatory activities. |
![]() |
V86903 | Chloranil | 118-75-2 | Chloranil activates the TLR4 signaling pathway by enhancing the expression of TLR4 and MyD88, leading to neuroinflammation and cell damage. |
![]() |
V51783 | CL-097 | 1026249-18-2 | CL097 is a potent TLR7 and TLR8 agonist that induces pro-inflammatory cytokines in macrophages. |
![]() |
V51012 | CL-104773 | 802980-92-3 | TLR2 antagonists; JAK2 inhibitor |
![]() |
V74355 | Cobitolimod | 1226822-98-5 | Cobitolimod is a DNA oligonucleotide agonist of TLR-9 with anti-inflammatory activity. |
![]() |
V74354 | Cobitolimod sodium | 1527479-55-5 | Cobitolimod sodium is a DNA oligonucleotide agonist of TLR-9 with anti-inflammatory activity. |
![]() |
V87020 | CpG ODN 10101 sodium | CpG ODN 10101 sodium is a synthetic oligodeoxynucleotide (ODN) that is a Toll-like receptor 9 (TLR9) agonist. | |
![]() |
V51027 | CU-115 | 2471982-20-2 | CU-115 is a disabling TLR8 antagonist (IC50=1.04 µM) and shows activity against TLR8 and TLR7 (IC50=>50 µM). |
![]() |
V3815 | CU-CPT-8m | 125079-83-6 | CU-CPT-8m is a novel, potent and specific antagonist ofToll-like receptor 8 (TLR8)with immunomodulatory effects. |
![]() |
V3816 | CU-CPT-9a | 2165340-32-7 | CU-CPT-9a, an analog ofCU-CPT-8m, is a potent and specificantagonist/inhibitor of TLR8 (Toll-like receptor 8) (IC50 = 0.5 nM) with the potential to be used for treating autoimmune diseases. |